Granulomatosis with Polyangiitis: all 107 studies
Page 1 of 2. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.Not yet recruitingNCT07451847Phase 4
- TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With PolyangiitisRecruitingNCT07176546Phase 2/3
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 3
- Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With PolyangiitisRecruitingNCT06940661Phase 2
- Eosinophil Subpopulations in Eosinophilic-associated DiseasesNot yet recruitingNCT06911775
- Special Drug Use-results Survey for Long-term Use（Avacopan）RecruitingNCT06758271
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.RecruitingNCT06581562Phase 1
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/2
- eGPA and Local Inflammation Within the Ear, Nose and Throat AreaRecruitingNCT06298448
- The Epigenomic Signature of Eosinophilic Granulomatosis With PolyangiitisNot yet recruitingNCT06231498
- Study of Salvage Therapy to Treat Patients With Granulomatosis With PolyangiitisRecruitingNCT04871191Phase 3
- Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing EosinophilsRecruitingNCT04538937
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT03004326
- VCRC Tissue RepositoryRecruitingNCT02967068
- Vasculitis Pregnancy RegistryRecruitingNCT02593565
- Pediatric Vasculitis InitiativeRecruitingNCT02006134
- One-Time DNA Study for VasculitisRecruitingNCT01241305
- PR3-AAV Resilient Remission or PRRRTerminatedNCT05376319Phase 2Results posted
- Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in JapanCompletedNCT04551989Results posted
- Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.CompletedNCT03895801Phase 2Results posted
- Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPATerminatedNCT03712345Phase 2Results posted
- Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921CompletedNCT03298061Phase 3Results posted
- Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated VasculitisCompletedNCT02169219Phase 4Results posted
- A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisCompletedNCT02020889Phase 3Results posted
- The Assessment of Prednisone In Remission Trial - Centers of Excellence ApproachCompletedNCT01940094Phase 3Results posted
- A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01750697Phase 2Results posted
- Rituximab Vasculitis Maintenance StudyCompletedNCT01697267Phase 3Results posted
- An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic PolyangiitisCompletedNCT01613599Results posted
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisCompletedNCT00987389Phase 3Results posted
- Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4Results posted
- Phase II Study on Gusperimus in Patients With Refractory Wegener's GranulomatosisCompletedNCT00530075Phase 2Results posted
- Abatacept in Treating Adults With Mild Relapsing Wegener's GranulomatosisCompletedNCT00468208Phase 1/2Results posted
- Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisCompletedNCT00104299Phase 2/3Results posted
- Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3CompletedNCT07712172
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPAActive, not recruitingNCT06868290Phase 2
- Iptacopan in Patients With ANCA Associated VasculitisActive, not recruitingNCT06388941Phase 2
- Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)Active, not recruitingNCT06294236Phase 1
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
- Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the OriginatorCompletedNCT05716334
- Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.CompletedNCT05703802
- Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male VolunteersStatus unknownNCT05353179Early Phase 1
- Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPAStatus unknownNCT04944524Phase 4
- Hydroxychloroquine in ANCA Vasculitis EvaluationTerminatedNCT04316494Phase 4
- PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable
- Rituximab and Belimumab Combination Therapy in PR3 VasculitisStatus unknownNCT03967925Phase 2
- TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With PolyangiitisActive, not recruitingNCT03919435Phase 1/2
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Cardiovascular Involvement in Patients With Granulomatosis With PolyangiitisStatus unknownNCT03782870
- Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated VasculitisCompletedNCT03698071Not applicable
- Low Dose Naltrexone to Improve Physical Health in Patients With VasculitisCompletedNCT03482479Phase 2
- Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 StudyWithdrawnNCT03182049
- Eosinophilic Granulomatosis With Polyangiitis CohortCompletedNCT03036670
- Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyStatus unknownNCT02947945Phase 2
- Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)Status unknownNCT02827734
- Rituximab for the Otolaryngologic Manifestations of Granulomatosis With PolyangiitisTerminatedNCT02626845Phase 4
- The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT02507024
- Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
- Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated VasculitisTerminatedNCT02474888
- Comparison Between a Long Term and a Conventional Maintenance Treatment With RituximabCompletedNCT02433522Phase 3
- Low-dose Glucocorticoid Vasculitis Induction StudyStatus unknownNCT02198248Phase 4
- VCRC Patient Contact Registry Patient-Reported Data Validation StudyCompletedNCT02190942
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary VasculitisStatus unknownNCT02126098
- A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic PolyangitisCompletedNCT02115997Phase 4
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)CompletedNCT02108860Phase 3
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachActive, not recruitingNCT01933724Phase 3
- Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)CompletedNCT01862068
- Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated VasculitisCompletedNCT01731561Phase 3
- PRO Development for ANCA Associated VasculitisStatus unknownNCT01729624
- BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel VasculitisWithdrawnNCT01598857Phase 2
- Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up StudyTerminatedNCT01586858
- Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's GranulomatosisTerminatedNCT01446211Phase 3
- Plasma Exchange for Renal VasculitisTerminatedNCT01408836Phase 2/3
- Alemtuzumab for ANCA Associated Refractory VasculitisStatus unknownNCT01405807Phase 4
- Study of One Protein Implicated in Wegener DiseaseCompletedNCT01167491Not applicable
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
- Anti-Cytokine Therapy for VasculitisCompletedNCT00753103Phase 2
- Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing VasculitidesStatus unknownNCT00751517Phase 2
- Efficacy Study of Two Treatments in the Remission of VasculitisCompletedNCT00748644Phase 3
- Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated VasculitidesCompletedNCT00430105Phase 2/3
- WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesStatus unknownNCT00349674Phase 3
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic PolyangiitisCompletedNCT00315393
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesCompletedNCT00307593Not applicable
- Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.CompletedNCT00138983Phase 3
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)CompletedNCT00103792Phase 3
- An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard TherapiesCompletedNCT00072592Phase 1
- Daclizumab to Treat Wegener's GranulomatosisCompletedNCT00040248Phase 2
- Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesStatus unknownNCT00006055Not applicable
- Etanercept for Wegener's GranulomatosisCompletedNCT00005007Phase 2/3
- Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis SyndromesCompletedNCT00004567Phase 2
- Etanercept to Treat Wegener's GranulomatosisCompletedNCT00001901Phase 2
- Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsCompletedNCT00001764Phase 1